These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 11987667)
1. [Renal markers and predictors, and renal and cardiovascular risk factors]. Fernández-Andrade C Nefrologia; 2002; 22 Suppl 1():2-29. PubMed ID: 11987667 [TBL] [Abstract][Full Text] [Related]
2. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
3. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Hoy WE; Mathews JD; McCredie DA; Pugsley DJ; Hayhurst BG; Rees M; Kile E; Walker KA; Wang Z Kidney Int; 1998 Oct; 54(4):1296-304. PubMed ID: 9767547 [TBL] [Abstract][Full Text] [Related]
4. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Chalmers L; Kaskel FJ; Bamgbola O Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221 [TBL] [Abstract][Full Text] [Related]
5. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report]. Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265 [TBL] [Abstract][Full Text] [Related]
6. Time to abandon microalbuminuria? Ruggenenti P; Remuzzi G Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239 [TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
8. [Overweight and obesity--risk factors in the development and progression of renal disease]. Sebeková K; Klassen A; Bahner U; Heidland A Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263 [TBL] [Abstract][Full Text] [Related]
9. [Perspectives on treatment of the renal failure]. Bertolini L; Maggiore U; Savazzi G Recenti Prog Med; 2006 Dec; 97(12):759-70. PubMed ID: 17252735 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of hyperuricaemia and gout. Viazzi F; Leoncini G; Pontremoli R Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532 [TBL] [Abstract][Full Text] [Related]
11. Renal disease in obesity: the need for greater attention. Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023 [TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular disease after renal transplantation]. Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047 [TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J; Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203 [TBL] [Abstract][Full Text] [Related]
15. Hypertension strategies for therapeutic intervention and prevention of end-organ damage. Houston MC Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795 [TBL] [Abstract][Full Text] [Related]